BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22361081)

  • 1. Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.
    Khan AJ; Vicini FA; Beitsch P; Goyal S; Kuerer HM; Keisch M; Quiet C; Zannis V; Keleher A; Snyder H; Gittleman M; Whitworth P; Fine R; Lyden M; Haffty BG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):323-30. PubMed ID: 22361081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial.
    Khan AJ; Vicini F; Beitsch P; Haffty B; Quiet C; Keleher A; Garcia D; Snider H; Gittleman M; Zannis V; Kuerer H; Whitacre E; Whitworth P; Fine R
    Ann Surg Oncol; 2009 Jun; 16(6):1612-8. PubMed ID: 19319606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI).
    Vicini F; Beitsch PD; Quiet CA; Keleher AJ; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer HM; Lyden M
    Cancer; 2008 Feb; 112(4):758-66. PubMed ID: 18181095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brachytherapy-based partial breast irradiation is associated with low rates of complications and excellent cosmesis.
    Shah C; Khwaja S; Badiyan S; Wilkinson JB; Vicini FA; Beitsch P; Keisch M; Arthur D; Lyden M
    Brachytherapy; 2013; 12(4):278-84. PubMed ID: 23664895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity.
    Vargo JA; Verma V; Kim H; Kalash R; Heron DE; Johnson R; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):285-91. PubMed ID: 24268787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.
    Vicini F; Beitsch P; Quiet C; Gittleman M; Zannis V; Fine R; Whitworth P; Kuerer H; Haffty B; Keisch M; Lyden M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):808-17. PubMed ID: 20472364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device.
    Mann JM; Osian AD; Brandmaier A; Yan W; Sung KJ; Siegel B; Fink S; Kaplan B; Fulman M; Wu G; Christos P; Nori D; Ravi A
    Clin Breast Cancer; 2016 Jun; 16(3):217-22. PubMed ID: 26948247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite(®) breast brachytherapy registry trial.
    Shah C; Badiyan S; Ben Wilkinson J; Vicini F; Beitsch P; Keisch M; Arthur D; Lyden M
    Ann Surg Oncol; 2013 Oct; 20(10):3279-85. PubMed ID: 23975302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated partial breast irradiation with low-dose-rate interstitial implant brachytherapy after wide local excision: 12-year outcomes from a prospective trial.
    Hattangadi JA; Powell SN; MacDonald SM; Mauceri T; Ancukiewicz M; Freer P; Lawenda B; Alm El-Din MA; Gadd MA; Smith BL; Taghian AG
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):791-800. PubMed ID: 22099046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial.
    Vicini FA; Beitsch PD; Quiet CA; Keleher A; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Kuerer H; Whitacre EB; Whitworth PW; Fine RE; Haffty BG; Arrambide LS
    Cancer; 2005 Sep; 104(6):1138-48. PubMed ID: 16088962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy registry trial.
    Khan AJ; Arthur D; Vicini F; Beitsch P; Kuerer H; Goyal S; Lyden M; Haffty BG
    Ann Surg Oncol; 2012 May; 19(5):1477-83. PubMed ID: 22109731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
    Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
    Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strut-based accelerated partial breast irradiation: Report of treatment results for 250 consecutive patients at 5 years from a multicenter retrospective study.
    Yashar C; Attai D; Butler E; Einck J; Finkelstein S; Han B; Hong R; Komarnicky L; Lyden M; Mantz C; Morcovescu S; Nigh S; Perry K; Pollock J; Reiff J; Scanderbeg D; Snyder M; Kuske R
    Brachytherapy; 2016; 15(6):780-787. PubMed ID: 27528591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer.
    Fowble B; Fein DA; Hanlon AL; Eisenberg BL; Hoffman JP; Sigurdson ER; Daly MB; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):669-77. PubMed ID: 8690632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data.
    Wilkinson JB; Beitsch PD; Shah C; Arthur D; Haffty BG; Wazer DE; Keisch M; Shaitelman SF; Lyden M; Chen PY; Vicini FA
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1179-85. PubMed ID: 23182700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with optimal cosmetic results at 36 months in patients treated with accelerated partial breast irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite Breast Brachytherapy Registry Trial.
    Goyal S; Khan AJ; Vicini F; Beitsch PD; Lyden M; Keisch M; Haffty BG
    Ann Surg Oncol; 2009 Sep; 16(9):2450-8. PubMed ID: 19517191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast.
    Jeruss JS; Vicini FA; Beitsch PD; Haffty BG; Quiet CA; Zannis VJ; Keleher AJ; Garcia DM; Snider HC; Gittleman MA; Whitacre E; Whitworth PW; Fine RE; Arrambide S; Kuerer HM
    Ann Surg Oncol; 2006 Jul; 13(7):967-76. PubMed ID: 16788759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial.
    Nelson JC; Beitsch PD; Vicini FA; Quiet CA; Garcia D; Snider HC; Gittleman MA; Zannis VJ; Whitworth PW; Fine RE; Keleher AJ; Kuerer HM
    Am J Surg; 2009 Jul; 198(1):83-91. PubMed ID: 19268900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.